BeiGene, Ltd. (BGNE) PT Raised to $190 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BGNE Hot Sheet
Price: $184.71 --0%
Rating Summary:
17 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Rating Summary:
17 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on BeiGene, Ltd. (NASDAQ: BGNE) to $190.00 (from $184.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
- Rakus Co Ltd (3923:JP) PT Raised to JPY1,300 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
